NZM2:ETR
Novozymes A/S
58,00 €
0,00%
(0,00) 1D
9 ოქტ, 17:35:30 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
57,64 €
High
58,10 €
Low
57,64 €
Mkt. cap
177,38 მლრ.
Avg. vol.
120,00
Volume
5,00
52-wk high
61,96 €
52-wk low
46,74 €
No. of employees
11 ათ.
Open
57,64 €
High
58,10 €
Low
57,64 €
Mkt. cap
177,38 მლრ.
Avg. vol.
120,00
Volume
5,00
52-wk high
61,96 €
52-wk low
46,74 €
No. of employees
11 ათ.
News stories
From web sources and news partners
El Dorado News-Times
·
16 წუთის წინ
Wall Street finishes its record-setting week with gains
24/7 Wall St.
·
42 წუთის წინ
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
MarketBeat
·
41 წუთის წინ
Immatics N.V. (NASDAQ:IMTX) Stock Has Consensus Target Price of $20.60 According to Brokerages
Seeking Alpha
·
51 წუთის წინ
S&P 500 Index Concentration - Room At The Top
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees11,1 ათ.
Founded2000
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com